Home/Pipeline/RAPID™ Biodynamic Haematogel

RAPID™ Biodynamic Haematogel

Diabetic Foot Ulcers (DFUs)

Phase 2Active

Key Facts

Indication
Diabetic Foot Ulcers (DFUs)
Phase
Phase 2
Status
Active
Company

About Biotherapy Services

Biotherapy Services is a private, clinical-stage biotech firm developing autologous biological therapies for wound healing, particularly diabetic foot ulcers and pressure sores. Its core asset is the RAPID™ Biodynamic Haematogel, a patient-specific gel that concentrates platelets and growth factors to stimulate the body's natural healing processes. The company is currently conducting a Phase 2/3 clinical trial (RAPID-1DFU) at multiple UK hospital sites and operates under GMP manufacturing standards. Founded in 2012, it represents a specialized player in the advanced wound care and regenerative medicine sector.

View full company profile

Other Diabetic Foot Ulcers (DFUs) Drugs

DrugCompanyPhase
Mirragen for Diabetic Foot UlcersETSCommercial
Wound HealingSayenza BiosciencesClinical